Icon

VIJOICE (nda215039)- (50MG,125MG,200MG)

ALPELISIB NOVARTIS
50MG,125MG,200MG
No No
2033-Apr-29 2024-May-24
None None
None No
VIJOICE is a kinase inhibitor indicated for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CARelated Overgrowth Spectrum (PROS) who require systemic therapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG ** ** - - -
125MG ** ** - - -
200MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.